scholarly article | Q13442814 |
P50 | author | Breandan N Kennedy | Q43116486 |
Nicole Kleinstreuer | Q43837661 | ||
Stephanie Padilla | Q56613305 | ||
Tamara Tal | Q59661475 | ||
Maria Bondesson | Q42704591 | ||
P2093 | author name string | Thomas Knudsen | |
Andrew Smith | |||
Alan Tennant | |||
Catherine W McCollum | |||
Claire Kilty | |||
Carlie LaLone | |||
P2860 | cites work | The antipsychotics haloperidol and chlorpromazine increase bone metabolism and induce osteopenia in female rats | Q42937534 |
Molecular target sequence similarity as a basis for species extrapolation to assess the ecological risk of chemicals with known modes of action | Q42997250 | ||
Dithiocarbamates induce craniofacial abnormalities and downregulate sox9a during zebrafish development | Q43041971 | ||
Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. | Q43792756 | ||
The atypical anti-psychotic clozapine decreases bone mass in rats in vivo | Q44583332 | ||
Angiogenesis inhibitors derived from thalidomide | Q46720083 | ||
Thalidomide (5HPP-33) suppresses microtubule dynamics and depolymerizes the microtubule network by binding at the vinblastine binding site on tubulin | Q47989598 | ||
Caffeine treatment disturbs the angiogenesis of zebrafish embryos. | Q50502953 | ||
Immediate and long-term consequences of vascular toxicity during zebrafish development. | Q50657097 | ||
Endothelial cell-derived non-canonical Wnt ligands control vascular pruning in angiogenesis. | Q50671696 | ||
Cartilage and bone malformations in the head of zebrafish (Danio rerio) embryos following exposure to disulfiram and acetic acid hydrazide. | Q51538351 | ||
Teratogenic mechanisms of medical drugs | Q22337136 | ||
Vascular endothelial cell growth-activated XBP1 splicing in endothelial cells is crucial for angiogenesis | Q24337309 | ||
CDD: a Conserved Domain Database for the functional annotation of proteins | Q24610576 | ||
A computational model predicting disruption of blood vessel development | Q27324767 | ||
Thalidomide-induced teratogenesis: history and mechanisms | Q28085087 | ||
MicroRNA-214 Is Upregulated in Heart Failure Patients and Suppresses XBP1-Mediated Endothelial Cells Angiogenesis | Q28115504 | ||
Selective inhibition of retinal angiogenesis by targeting PI3 kinase | Q28471888 | ||
Toxicogenomic and phenotypic analyses of bisphenol-A early-life exposure toxicity in zebrafish | Q28478402 | ||
Quercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cells | Q28480617 | ||
The zebrafish reference genome sequence and its relationship to the human genome | Q29616593 | ||
MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis | Q30495845 | ||
Building predictive models for mechanism-of-action classification from phenotypic assay data sets | Q30671097 | ||
Elucidating mechanisms of toxicity using phenotypic data from primary human cell systems--a chemical biology approach for thrombosis-related side effects | Q30883298 | ||
Predictive model of rat reproductive toxicity from ToxCast high throughput screening | Q31009589 | ||
Endocrine profiling and prioritization of environmental chemicals using ToxCast data | Q33687961 | ||
MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling | Q33799083 | ||
Environmental impact on vascular development predicted by high-throughput screening | Q33970802 | ||
Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data | Q34004475 | ||
Zebrafish developmental screening of the ToxCast™ Phase I chemical library. | Q34105781 | ||
Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. | Q34979500 | ||
Methyl tert butyl ether targets developing vasculature in zebrafish (Danio rerio) embryos | Q35230207 | ||
Rspo1/Wnt signaling promotes angiogenesis via Vegfc/Vegfr3 | Q35445281 | ||
Role of shear-stress-induced VEGF expression in endothelial cell survival | Q35851527 | ||
Multidimensional in vivo hazard assessment using zebrafish | Q37412007 | ||
Developmental and pathological angiogenesis | Q37901035 | ||
Disruption of embryonic vascular development in predictive toxicology | Q37978259 | ||
Identification of vascular disruptor compounds by analysis in zebrafish embryos and mouse embryonic endothelial cells. | Q38731560 | ||
Semaphorin-plexin signaling guides patterning of the developing vasculature. | Q40538400 | ||
Bisphenol A affects placental layers morphology and angiogenesis during early pregnancy phase in mice. | Q42701517 | ||
P921 | main subject | Danio rerio | Q169444 |
ichthyotoxicity | Q113562277 | ||
P304 | page(s) | 70-81 | |
P577 | publication date | 2016-12-19 | |
P1433 | published in | Reproductive Toxicology | Q15633823 |
P1476 | title | Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity | |
P478 | volume | 70 |
Q52574126 | 3S - Systematic, systemic, and systems biology and toxicology |
Q36299276 | Applying evolutionary genetics to developmental toxicology and risk assessment. |
Q47872889 | Assaying uptake of endocrine disruptor compounds in zebrafish embryos and larvae |
Q89669447 | Blood-brain barrier development: Systems modeling and predictive toxicology |
Q57173586 | Cardiopulmonary consequences of gestational toxicant exposure: Symposium overview at the 56th annual SOT meeting, Baltimore, MD |
Q61807156 | Construction of a Quantitative Structure Activity Relationship (QSAR) Model to Predict the Absorption of Cephalosporins in Zebrafish for Toxicity Study |
Q38773099 | Embryonic vascular disruption adverse outcomes: Linking high throughput signaling signatures with functional consequences. |
Q89964189 | Evaluation of the Developmental Toxicity Induced by E804 in Zebrafish Embryos |
Q92617261 | Orthogonal Drug Pooling Enhances Phenotype-Based Discovery of Ocular Antiangiogenic Drugs in Zebrafish Larvae |
Q48031436 | Quantification of Estradiol Uptake in Zebrafish Embryos and Larvae |
Q89586015 | Systems Modeling of Developmental Vascular Toxicity |
Q89833307 | Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion |
Search more.